ZIEGLER JOSEPH 4
4 · TherapeuticsMD, Inc. · Filed Aug 21, 2023
Insider Transaction Report
Form 4
ZIEGLER JOSEPH
Principal Financial Officer
Transactions
- Award
Common Stock
2023-08-17+7,500→ 7,500 total
Footnotes (1)
- [F1]These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan).